GENETIC COUNSELING SHARED RESOURCE ABSTRACT The Genetic Counseling Shared Resource (GC) facilitates basic science, clinical, and behavioral research necessary to translate genetic discoveries into clinical care. GC has provided clinical genetics services and supported genetic research at Huntsman Cancer Institute (HCI) since 2003 (supported by the Cancer Center Support Grant since 2009) and has been directed by Wendy Kohlmann, MS, CGC, since 2006. GC is quintessential to HCI?s mission and builds on HCI?s long history of gene discovery by leading practice-changing research endeavors to determine the clinical utility of genetic testing, optimal methods for risk communication and delivery of genetic counseling, and strategies to manage risk conveyed by inherited cancer predispositions. GC is integral to a major goal of the Cancer Center, bringing scientific discoveries to the clinic and into applications for the population. GC provides several key services necessary for translational genetic research, including identifying cohorts of patients for gene research or studies of syndromes; helping investigators design studies to optimally incorporate genetic information and to anticipate and address ethical, legal, and social issues related to genetic analysis; providing genetic counseling interventions; and collecting clinical phenotypes and longitudinal outcomes data.
The aims of GC are 1) to provide cancer genetics expertise, genetic counseling services, and interventions, and 2) to support the scientific research objectives of the Cancer Center, especially in the context of translation of genetics to the clinic and population. Access to research genetic counseling services has allowed Cancer Center members to study novel approaches for providing genetic information and to include participants across our catchment area, the State of Utah. GC adds value to the Cancer Center by ensuring genetics expertise is available to all Cancer Center members and clinical investigators. The broad impact of GC across HCI is indicated by its contribution to 61 publications since 2014. Cancer Center members with peer-reviewed funding comprise 53% of the users, and 100% of GC?s work is cancer-related. HCI?s establishment of a top-quality, research-oriented Genetic Counseling Shared Resource is highly innovative and unique among National Cancer Institute cancer centers. The Director and staff of the Shared Resource participate in national committees, and they extend the impact of HCI research by incorporating findings into guidelines for genetic testing and management of hereditary cancer. GC allows HCI to excel in all areas of hereditary cancer research and to be a leader in genetic discoveries and translation of findings into clinical implementation and population policy.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA042014-31
Application #
9935880
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2020-04-01
Budget End
2021-03-31
Support Year
31
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of Utah
Department
Type
DUNS #
009095365
City
Salt Lake City
State
UT
Country
United States
Zip Code
84112
Tavtigian, Sean V; Greenblatt, Marc S; Harrison, Steven M et al. (2018) Modeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework. Genet Med 20:1054-1060
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Unusual Isothermal Hysteresis in DNA i-Motif pH Transitions: A Study of the RAD17 Promoter Sequence. Biophys J 114:1804-1815
Rogers, R Aaron; Fleming, Aaron M; Burrows, Cynthia J (2018) Rapid Screen of Potential i-Motif Forming Sequences in DNA Repair Gene Promoters. ACS Omega 3:9630-9635
Wei, Xiaomu; Calvo-Vidal, M Nieves; Chen, Siwei et al. (2018) Germline Lysine-Specific Demethylase 1 (LSD1/KDM1A) Mutations Confer Susceptibility to Multiple Myeloma. Cancer Res 78:2747-2759
Barrott, Jared J; Illum, Benjamin E; Jin, Huifeng et al. (2018) Paracrine osteoprotegerin and ?-catenin stabilization support synovial sarcomagenesis in periosteal cells. J Clin Invest 128:207-218
Sample, Danielle C; Samadder, N Jewel; Pappas, Lisa M et al. (2018) Variables affecting penetrance of gastric and duodenal phenotype in familial adenomatous polyposis patients. BMC Gastroenterol 18:115
Delker, Don A; Wood, Austin C; Snow, Angela K et al. (2018) Chemoprevention with Cyclooxygenase and Epidermal Growth Factor Receptor Inhibitors in Familial Adenomatous Polyposis Patients: mRNA Signatures of Duodenal Neoplasia. Cancer Prev Res (Phila) 11:4-15
Madsen, Michael J; Knight, Stacey; Sweeney, Carol et al. (2018) Reparameterization of PAM50 Expression Identifies Novel Breast Tumor Dimensions and Leads to Discovery of a Genome-Wide Significant Breast Cancer Locus at 12q15. Cancer Epidemiol Biomarkers Prev 27:644-652
Trott, Daniel W; Henson, Grant D; Ho, Mi H T et al. (2018) Age-related arterial immune cell infiltration in mice is attenuated by caloric restriction or voluntary exercise. Exp Gerontol 109:99-107
Wu, Yelena P; Parsons, Bridget G; Mooney, Ryan et al. (2018) Barriers and Facilitators to Melanoma Prevention and Control Behaviors Among At-Risk Children. J Community Health 43:993-1001

Showing the most recent 10 out of 1193 publications